Connect with us

Health

French Firm Biogaran Acquires Nigeria’s Swipha

Published

on

By Modupe Gbadeyanka

Foremost Nigerian pharmaceutical company, Swiss Pharma Nigeria Ltd, commonly referred to as Swipha, has been acquired by a new investor called Biogaran.

Biogaran is a subsidiary of Servier, which is the number two French pharmaceutical group that specialises in generics.

Commenting on the acquisition, President of Biogaran, Mr Pascal Brière, said, “Swipha’s know-how, network and reputation immediately convinced us that it was the right partner for us.”

Biogaran said it chose Nigeria to realise its first investment in Africa because of the many long-term opportunities offered by the country, which is Africa’s most populous.

“Nigeria quickly established itself as the best point of entry on the African continent, with 184 million potential consumers and strong economic fundamentals, including a dynamic market economy,” Mr Brière stated.

This development comes at a time Nigeria is battling with its economy, which is finding its way out of recession.

Swipha is a drug production and distribution firm incorporated in 1976 and is famous for its quality.

It was the first Nigerian pharmaceutical company to obtain “ISO 9001:2008” certification in 2007 and was given WHO GMP certification by the World Health Organisation (WHO) in 2014.

It has over 300 Nigerians on its payroll and had a turnover of N4 billion before the crisis.

Beyond its production unit, the company also controls an extensive distribution network covering most of Nigeria.

Biogaran says it is interested in developing Swipha’s portfolio, which is mainly focused on anxiolytics and tranquilisers, antimalarials and antibiotics.

Modupe Gbadeyanka is a fast-rising journalist with Business Post Nigeria. Her passion for journalism is amazing. She is willing to learn more with a view to becoming one of the best pen-pushers in Nigeria. Her role models are the duo of CNN's Richard Quest and Christiane Amanpour.

Click to comment

Leave a Reply

Health

AAN Seeks Swift Government Actions on Albinism Related Health Crisis

Published

on

Albinism association Workers Day

By Adedapo Adesanya

The Albinism Association of Nigeria (AAN) has intensified its call for swift actions by government and policymakers over the escalating health crisis facing persons with albinism (PWAs) in Nigeria.

The call came as the world marked World Cancer Day on February 4, 2025 under the theme United by Unique.

In a statement signed by the president of the association, Mrs Bisi Bamishe, the group said, “Our people are dying in silence, with little to no awareness of the immense health challenges we endure, particularly the devastating impact of skin cancer.

“Despite our continuous advocacy efforts, the plight of persons with albinism remains largely unaddressed, and the consequences are dire. Within just a few days, we have lost three of our beloved members to this ravaging disease.”

The group highlighted the graveness of the issue, adding that, many others are battling for their lives without access to proper medical care.

“The grim reality is that the community of persons with albinism in Nigeria is under siege, and urgent action is required to prevent further loss of lives.”

AAN used the calender event to call on the government across several tiers to join the fight and improve their inputs.

“The absence of structured government interventions, including access to free or subsidized skin cancer treatments, preventive measures such as sunscreen distribution, and specialized dermatological care, has left our community in a state of despair. Without immediate action, we will continue to witness the preventable deaths of our members,” the group lamented.

“We call on the federal, state, and local governments, the legislative arms at all levels, well-meaning individuals, local and international donors, and relevant stakeholders to stand with us in the fight against this dreaded disease,” it added.

It also noted that it has not rested on its oars with it’s multiple approach to raise awareness about the pressing health needs of persons with albinism.

“We have engaged policymakers, health authorities, and legislators, urging them to implement sustainable policies that will ensure access to affordable healthcare, routine skin cancer screening, and the provision of lifesaving treatments for affected persons.

“However, the time for mere discussions has passed. We need tangible, swift, and decisive actions to save lives,” the group added.

The association lauded the efforts and responsiveness of the Lagos State government and called on other states to follow in its footsteps.

“We must acknowledge the efforts of some state governors, development partners and NGOs that have done a lot for us. Special appreciation goes to Lagos State Government that has spent over N20 million on skin cancer patients in the last two years as well as provision of sunscreen, hats and umbrellas. We hope other states can follow suit as much as possible.”

Continue Reading

Health

Nigeria Tightens Surveillance at Entry Point Amid Fresh Ebola Outbreak

Published

on

ebola dr congo

By Adedapo Adesanya

Nigeria has tightened surveillance measures at entry points in the country owing to a fresh outbreak of Ebola disease in Uganda.

Last week, the Ugandan Ministry of Health confirmed the outbreak of the disease with one death and has now followed up with forty-four contacts.

With the latest development, the Director-General of the Nigeria Centre for Disease Control (NCDC), Mr Jide Idris, in an advisory said although Nigeria has not recorded any outbreak of the disease, it is putting in place preventive measures.

“There are no cases of Ebola virus disease in Nigeria. However, the Nigeria Centre for Disease Control and Prevention (NCDC), in collaboration with relevant Ministries, Departments, Agencies, and Partners through the National Emerging Viral Hemorrhagic Diseases (EVHD) Technical Working Group, continues to monitor disease occurrence and has initiated measures to strengthen our preparedness in the country.

“These include the update of our EVD emergency contingency plan, heightened surveillance especially at the points of entry, and optimizing diagnostic capacity for EVD testing in designated laboratories in cities with international airports of entry and the National Reference Laboratory. In addition, all Lassa Fever testing laboratories can be activated to scale up testing if the need arises.”

According to the NCDC DG, there are no Ebola vaccines in Nigeria at the moment.

“There are vaccines and therapeutics available for some strains of the Ebola virus. The approved vaccine for the Zaire species (EBV) is not currently available in the country but can be obtained from the WHO Afro and does not protect against the Sudan virus,” he said.

However, the NCDC boss said, “Early recognition, isolation of patients, and initiation of supportive treatment, implementing infection and control measures in health facilities and homes, tracing and monitoring of contacts, and safe burial practices, significantly reduce morbidity and the probability of death.”

Ebola disease is a severe, and often fatal disease caused by the Ebola virus. It is transmitted to humans via contact with wild animals and spreads through human-to-human transmission via direct contact with bodily fluids of infected individuals or contaminated surfaces.

Symptoms may include fever, fatigue, muscle pain, headache, vomiting, diarrhoea, internal and external bleeding. It may appear 2 to 21 days after infection. Medical expertise are advised by the NCDC, in regard to this disease.

Continue Reading

Health

i3 Shifts 3rd Cohorts Focus to Growth-Stage Healthtechs After Trump’s Orders

Published

on

health financing fg

By Adedapo Adesanya

Investing in Innovation Africa (i3), a pan-African initiative to support African health-tech startups to commercialise and scale their offerings has decided to make a pivotal change to its third cohort selection to prioritise the immediate support for 5-7 growth-stage companies building the future of pharmacy care in Africa.

This comes after the US State Department’s “stop-work” directive for foreign aid issued on January 25, which is anticipated to impact the distribution of essential medicine in Africa’s healthcare supply chains.

President Donald Trump issued the executive order freezing US foreign development assistance for 90 days upon assuming office.

One of the affected by the order is the US Agency for International Development (USAID), which offers humanitarian and development assistance to other countries, primarily by giving fundings to non-governmental organisations, governments, and others. USAID is crucial in combating HIV/AIDS and other health matters.

According to a statement shared with Business Post on Monday, i3 says the order highlights and intensifies the need for locally-driven, market-creating approaches to health product distribution and service delivery across Africa.

So now the programme funded by the Gates Foundation, MSD, Cencora, Endless Foundation, HELP Logistics (a subsidiary of the Kühne Foundation), Sanofi’s Global Health Unit and Chemonics, will concentrate its immediate efforts on helping innovative growth-stage startups unlock major partnerships to rapidly expand access to patient care.

Fifteen leading startups will be selected for this cohort including 10 early-stage startups innovating in healthcare delivery or product distribution and five growth-stage startups building the future of pharmacy care.

Early-stage startups will receive a $50,000 grant and growth-stage startups will receive a $225,000 grant to unlock major partnerships that can expand patient access across the continent.

For startups in the cohort,  i3 aims to facilitate at least 150 relationships with key healthcare organizations, worth at least $30M,  which will expand patient access while creating valuable local jobs.

Entries for the 3rd cohort are open until February 28 after which the selected startups will be announced on April 30.

Launched in 2022, i3 has empowered 60 African health innovators across 16  countries, exceeding expectations with 43 per cent women-led and 20 per cent Francophone-led ventures.

Continue Reading

Trending